Drugs / Mesenchymal stem cells derived from umbilical cord
Mesenchymal stem cells derived from umbilical cord
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT06884904 | Apr 2025 → Apr 2027 expected | liver disorder | National Engineering Center of Cell Products | Not yet recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01873547 | Jun 2012 → Oct 2014 | spinal cord injury | General Hospital of Chinese Armed Police Forces | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mesenchymal stem cells derived from umbilical cord | “Mesenchymal stem cells derived from umbilical cord are transplanted directly into subarachnoid by Lumbar puncture.” NCT01873547 ↗1“injectable mesenchymal stem cells derived from umbilical cord” NCT06884904 ↗ |
| Modality | Cell therapy | “cell therapy including four times stem cells transplant via intrathecal injection.” NCT01873547 ↗ |
| Route | Intrathecal | “cell therapy including four times stem cells transplant via intrathecal injection.” NCT01873547 ↗ |